Dear Lung Cancer Colleagues:
It is my pleasure and privilege to invite you to join me for this virtual conference, Perspectives in Lung Cancer Care: A Virtual Forum Designed to Address Clinical Challenges with the Goal to Improve Patient Outcomes. Over the three days from March 17-19, 2022, this innovative CME/CE experience will take you on a unique learning journey, which begins when you enter the Virtual Conference Center. In this space, 8 livestreamed sessions will present the latest education in lung cancer and discuss practical application of emerging advances into clinical care.
The comprehensive agenda includes the most relevant topics that impact lung cancer practice today. At a glance, these are:
Session I: Targeted Therapy in NSCLC Part 1
Session II: Targeted Therapy in NSCLC Part 2
Session III: Immunotherapy in NSCLC
Session IV: Management of SCLC
Session V: Mesothelioma
Session VI: Early Stage and Locally Advanced NSCLC Management
Session VII: Lung Cancer Screening and Early Detection
Session VIII: Clinical Case Discussion
Nationally renowned faculty experts will engage you and your fellow learners in the live virtual sessions. We invite you to take a seat in the Live Theater, where audience interaction will be enhanced by polling and ample time for Q&A, and you can share your best practices and find solutions to your most difficult clinical challenges.
And, as in any live conference venue, you will find robust opportunities to interact with your colleagues beyond the educational sessions. There is much to explore, and comfortable walking shoes are not required!
Should you be unable to attend, each recorded and accredited session will be available as enduring content on Medscape Oncology in a few weeks' time. The educational content will be CME/CE-certified for an additional year.
I hope you will enjoy this one-of-a-kind virtual conference, benefit from the learning opportunities, and gather many clinical pearls to “bring home” to your practice!
Sincerely,
Lecia V. Sequist, MD, MPH
Conference Chair
The Landry Family Professor of Medicine
Harvard Medical School
Director, Center for Innovation in Early Cancer Detection
Massachusetts General Hospital
Boston, MA
PROGRAM CHAIR
AGENDA
Select a session below to view more details.
MARCH 17, 2022
MARCH 18, 2022
MARCH 19, 2022
ENHANCE YOUR EXPERIENCE WITH MEDCHALLENGE!
This event features MedChallenge, a new feature from Medscape that allows you to go head-to-head against your peers in a series of medical questions. Earn points, deepen your knowledge, and fight for the top spot on the leaderboard!
Founded by patients and survivors, GO2 Foundation for Lung Cancer, transforms survivorship as the world’s leading organization dedicated to saving, extending, and improving the lives of those vulnerable, at risk, and diagnosed with lung cancer. We work to change the reality of living with lung cancer by ending stigma, increasing public and private research funding, and ensuring access to care.
